These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33989755)

  • 21. Cell-Based Assays on Microfluidics for Drug Screening.
    Liu X; Zheng W; Jiang X
    ACS Sens; 2019 Jun; 4(6):1465-1475. PubMed ID: 31074263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Convergence of Stem Cell Technologies and Phenotypic Drug Discovery.
    Friese A; Ursu A; Hochheimer A; Schöler HR; Waldmann H; Bruder JM
    Cell Chem Biol; 2019 Aug; 26(8):1050-1066. PubMed ID: 31231030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of three-dimensional cell culture in therapeutics and diagnostics: an updated review.
    Biju TS; Priya VV; Francis AP
    Drug Deliv Transl Res; 2023 Sep; 13(9):2239-2253. PubMed ID: 36971997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. OrganDots--an organotypic 3D tissue culture platform for drug development.
    Sundstrom L; Biggs T; Laskowski A; Stoppini L
    Expert Opin Drug Discov; 2012 Jun; 7(6):525-34. PubMed ID: 22607235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The multicellular tumor spheroid model for high-throughput cancer drug discovery.
    LaBarbera DV; Reid BG; Yoo BH
    Expert Opin Drug Discov; 2012 Sep; 7(9):819-30. PubMed ID: 22788761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A simple, reliable method for high-throughput screening for diabetes drugs using 3D β-cell spheroids.
    Amin J; Ramachandran K; Williams SJ; Lee A; Novikova L; Stehno-Bittel L
    J Pharmacol Toxicol Methods; 2016; 82():83-89. PubMed ID: 27554916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementation and Use of State-of-the-Art, Cell-Based In Vitro Assays.
    Langer G
    Handb Exp Pharmacol; 2016; 232():171-90. PubMed ID: 26424721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Grafting of 3D Bioprinting to In Vitro Drug Screening: A Review.
    Nie J; Gao Q; Fu J; He Y
    Adv Healthc Mater; 2020 Apr; 9(7):e1901773. PubMed ID: 32125787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Could 3D models of cancer enhance drug screening?
    Brancato V; Oliveira JM; Correlo VM; Reis RL; Kundu SC
    Biomaterials; 2020 Feb; 232():119744. PubMed ID: 31918229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 2016 TEDD Annual Meeting, 27. October 2016, ZHAW Wädenswil.
    Heinzelmann E
    Chimia (Aarau); 2017 Feb; 71(1-2):47-49. PubMed ID: 28259198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advanced Multi-Dimensional Cellular Models as Emerging Reality to Reproduce
    Bassi G; Grimaudo MA; Panseri S; Montesi M
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consideration of the cellular microenvironment: physiologically relevant co-culture systems in drug discovery.
    L Berg E; Hsu YC; Lee JA
    Adv Drug Deliv Rev; 2014 Apr; 69-70():190-204. PubMed ID: 24524933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemoresistance of Cancer Cells: Requirements of Tumor Microenvironment-mimicking
    Jo Y; Choi N; Kim K; Koo HJ; Choi J; Kim HN
    Theranostics; 2018; 8(19):5259-5275. PubMed ID: 30555545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three-Dimensional Spheroids as In Vitro Preclinical Models for Cancer Research.
    Pinto B; Henriques AC; Silva PMA; Bousbaa H
    Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33291351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reconstituted Human Organ Models as a Translational Tool for Human Organ Response: Definition, Expectations, Cases, and Strategies for Implementation in Drug Discovery and Development.
    Tetsuka K; Ohbuchi M; Kawabe T; Goto T; Kiyonaga F; Takama K; Yamazaki S; Fujimori A
    Biol Pharm Bull; 2020; 43(3):375-383. PubMed ID: 32115499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perfusion Stirred-Tank Bioreactors for 3D Differentiation of Human Neural Stem Cells.
    Simão D; Arez F; Terasso AP; Pinto C; Sousa MF; Brito C; Alves PM
    Methods Mol Biol; 2016; 1502():129-42. PubMed ID: 27032948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3D in vitro technology for drug discovery.
    Hosseinkhani H
    Curr Drug Saf; 2012 Feb; 7(1):37-43. PubMed ID: 22663957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of challenges and prospects of 3D cell-based culture models used for studying drug induced liver injury during early phases of drug development.
    Chipangura JK; Ntamo Y; Mohr B; Chellan N
    Hum Exp Toxicol; 2023; 42():9603271221147884. PubMed ID: 36879529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug discovery through stem cell-based organoid models.
    Ranga A; Gjorevski N; Lutolf MP
    Adv Drug Deliv Rev; 2014 Apr; 69-70():19-28. PubMed ID: 24582599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3D bioprinting for high-throughput screening: Drug screening, disease modeling, and precision medicine applications.
    Mazzocchi A; Soker S; Skardal A
    Appl Phys Rev; 2019 Mar; 6(1):. PubMed ID: 33738018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.